Eyerising International

Eyerising International is an Australian medical technology company dedicated to advancing repeated low-level red-light (RLRL) therapy for childhood myopia management across the globe. The company was co-founded by Professor Mingguang He and Jason Sun, and is based in Melbourne, Australia. Its patented technology is registered on the Australian Register of Therapeutic Goods (ARTG 412752) and operates across more than 40 countries.

Eyerising International was established in Melbourne, Australia, with the mission of bringing RLRL therapy to families worldwide. It was co-founded by Professor Mingguang He and Jason Sun. The company achieved CE marking for European markets and registered its device on the Australian Register of Therapeutic Goods (ARTG 412752).

• Eyerising Myopia Management Device

  A home-use medical device indicated for myopia control, available only through optometrists and ophthalmologists. It uses patented repeated low-level red-light (RLRL) technology to emit visible red light from a laser diode, delivered to the back of the eye to slow myopia progression by slowing the elongation of the eye.

1. Eyerising International - Advancing Myopia Management
2. About Us - Eyerising International
3. Our Story - Eyerising International
4. Our Device - Eyerising International